303 related articles for article (PubMed ID: 19205055)
41. Expression of matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase (TIMP-1) in tissues with a diagnosis of childhood lymphoma.
Bozkurt C; Ertem U; Oksal A; Sahin G; Yüksek N; Birgen D
Pediatr Hematol Oncol; 2008 Sep; 25(7):621-9. PubMed ID: 18850474
[TBL] [Abstract][Full Text] [Related]
42. Roles of matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases 1 in acute encephalopathy following prolonged febrile seizures.
Suenaga N; Ichiyama T; Kubota M; Isumi H; Tohyama J; Furukawa S
J Neurol Sci; 2008 Mar; 266(1-2):126-30. PubMed ID: 17928006
[TBL] [Abstract][Full Text] [Related]
43. Determination of selenium in serum samples of preterm newborn infants with bronchopulmonary dysplasia using a validated hydride generation system.
Mostafa-Gharehbaghi M; Mostafa-Gharabaghi P; Ghanbari F; Abdolmohammad-Zadeh H; Sadeghi GH; Jouyban A
Biol Trace Elem Res; 2012 Jun; 147(1-3):1-7. PubMed ID: 22144015
[TBL] [Abstract][Full Text] [Related]
44. Levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 are related to cardiopulmonary injury in fetal inflammatory response syndrome.
Yan Y; Jiang L; Li M; Zhang H; Shen Y; Zhang W; Zhang W
Clinics (Sao Paulo); 2020; 75():e2049. PubMed ID: 33263620
[TBL] [Abstract][Full Text] [Related]
45. Early hypoadrenalism in premature infants at risk for bronchopulmonary dysplasia or death.
Nykänen P; Anttila E; Heinonen K; Hallman M; Voutilainen R
Acta Paediatr; 2007 Nov; 96(11):1600-5. PubMed ID: 17888053
[TBL] [Abstract][Full Text] [Related]
46. Cord blood KL-6, a specific lung injury marker, correlates with the subsequent development and severity of atypical bronchopulmonary dysplasia.
Kim DH; Kim HS; Shim SY; Lee JA; Choi CW; Kim EK; Kim BI; Choi JH
Neonatology; 2008; 93(4):223-9. PubMed ID: 18025794
[TBL] [Abstract][Full Text] [Related]
47. Bronchopulmonary dysplasia - prevalence, severity and predictive factors in a national cohort of extremely premature infants.
Farstad T; Bratlid D; Medbø S; Markestad T;
Acta Paediatr; 2011 Jan; 100(1):53-8. PubMed ID: 20653607
[TBL] [Abstract][Full Text] [Related]
48. Lymphocyte subpopulations in bronchopulmonary dysplasia.
Ballabh P; Simm M; Kumari J; Krauss AN; Jain A; Auld PA; Cunningham-Rundles S
Am J Perinatol; 2003 Nov; 20(8):465-75. PubMed ID: 14703595
[TBL] [Abstract][Full Text] [Related]
49. Endostatin concentration in cord plasma predicts the development of bronchopulmonary dysplasia in very low birth weight infants.
Janér J; Andersson S; Kajantie E; Lassus P
Pediatrics; 2009 Apr; 123(4):1142-6. PubMed ID: 19336373
[TBL] [Abstract][Full Text] [Related]
50. Eosinophil activation in preterm infants with lung disease.
Broström EB; Katz-Salamon M; Lundahl J; Halldén G; Winbladh B
Acta Paediatr; 2007 Jan; 96(1):23-8. PubMed ID: 17187598
[TBL] [Abstract][Full Text] [Related]
51. Circulating endothelial progenitor cells in preterm infants with bronchopulmonary dysplasia.
Borghesi A; Massa M; Campanelli R; Bollani L; Tzialla C; Figar TA; Ferrari G; Bonetti E; Chiesa G; de Silvestri A; Spinillo A; Rosti V; Stronati M
Am J Respir Crit Care Med; 2009 Sep; 180(6):540-6. PubMed ID: 19574444
[TBL] [Abstract][Full Text] [Related]
52. The epidemiology of atypical chronic lung disease in extremely low birth weight infants.
Streubel AH; Donohue PK; Aucott SW
J Perinatol; 2008 Feb; 28(2):141-8. PubMed ID: 18059466
[TBL] [Abstract][Full Text] [Related]
53. Low levels of tissue inhibitors of metalloproteinases with a high matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio are present in tracheal aspirate fluids of infants who develop chronic lung disease.
Ekekezie II; Thibeault DW; Simon SD; Norberg M; Merrill JD; Ballard RA; Ballard PL; Truog WE
Pediatrics; 2004 Jun; 113(6):1709-14. PubMed ID: 15173495
[TBL] [Abstract][Full Text] [Related]
54. Amplitude-integrated EEG differences in premature infants with and without bronchopulmonary dysplasia: a cross-sectional study.
Sommers R; Tucker R; Laptook A
Acta Paediatr; 2011 Nov; 100(11):1437-41. PubMed ID: 21722174
[TBL] [Abstract][Full Text] [Related]
55. Abnormal oral mucosal light reflectance in bronchopulmonary dysplasia.
De Felice C; Parrini S; Barducci A; Chitano G; Tonni G; Latini G
Early Hum Dev; 2006 Apr; 82(4):273-8. PubMed ID: 16338107
[TBL] [Abstract][Full Text] [Related]
56. Epithelial lining fluid free IGF-I-to-PAPP-A ratio is associated with bronchopulmonary dysplasia in preterm infants.
Capoluongo E; Ameglio F; Lulli P; Minucci A; Santonocito C; Concolino P; Di Stasio E; Boccacci S; Vendettuoli V; Giuratrabocchetta G; De Cunto A; Tana M; Romagnoli C; Zuppi C; Vento G
Am J Physiol Endocrinol Metab; 2007 Jan; 292(1):E308-13. PubMed ID: 16954333
[TBL] [Abstract][Full Text] [Related]
57. Circulating matrix metalloproteinase-8 (MMP-8) and MMP-9 are increased in chronic periodontal disease and decrease after non-surgical periodontal therapy.
Marcaccini AM; Novaes AB; Meschiari CA; Souza SL; Palioto DB; Sorgi CA; Faccioli LH; Tanus-Santos JE; Gerlach RF
Clin Chim Acta; 2009 Nov; 409(1-2):117-22. PubMed ID: 19751716
[TBL] [Abstract][Full Text] [Related]
58. Spectrum of clinical and cardiac dysfunction in bronchopulmonary dysplasia: early prediction of long-term morbidity.
Shekhawat PS; Fong LV; Mitvalsky J; Yu VY
J Perinatol; 1997; 17(2):95-100. PubMed ID: 9134505
[TBL] [Abstract][Full Text] [Related]
59. Matrix metalloproteinase-9 and matrix metalloproteinase-2 as biomarkers of various courses in multiple sclerosis.
Benesová Y; Vasku A; Novotná H; Litzman J; Stourac P; Beránek M; Kadanka Z; Bednarík J
Mult Scler; 2009 Mar; 15(3):316-22. PubMed ID: 19153173
[TBL] [Abstract][Full Text] [Related]
60. Time-related changes in steroid use and bronchopulmonary dysplasia in preterm infants.
Yoder BA; Harrison M; Clark RH
Pediatrics; 2009 Aug; 124(2):673-9. PubMed ID: 19620192
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
